Abstract:BACKGROUND:Diabetes mellitus is characterized by loss or dysfunction of insulin-producing β-cells in the pancreas, resulting in failure of blood glucose regulation and devastating secondary complications. Thus, β-cells are currently the prime target for cell-replacement and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-cell mass and normoglycemia in diabetic patients. Potential strategies include targeting specific β-cell subpopulations to increase proliferation or maturation. Alternatively, transdifferentiation of pancreatic islet cells (e.g. α- or δ-cells), extra-islet cells (acinar and ductal cells), hepatocytes, or intestinal cells into insulin-producing cells might improve glycemic control. To this end, it is crucial to systematically characterize and unravel the transcriptional program of all pancreatic cell types at the molecular level in homeostasis and disease. Furthermore, it is necessary to better determine the underlying mechanisms of β-cell maturation, maintenance, and dysfunction in diabetes, to identify and molecularly profile endocrine subpopulations with regenerative potential, and to translate the findings from mice to man. Recent approaches in single-cell biology started to illuminate heterogeneity and plasticity in the pancreas that might be targeted for β-cell regeneration in diabetic patients.SCOPE OF REVIEW:This review discusses recent literature on single-cell analysis including single-cell RNA sequencing, single-cell mass cytometry, and flow cytometry of pancreatic cell types in the context of mechanisms of endogenous β-cell regeneration. We discuss new findings on the regulation of postnatal β-cell proliferation and maturation. We highlight how single-cell analysis recapitulates described principles of functional β-cell heterogeneity in animal models and adds new knowledge on the extent of β-cell heterogeneity in humans as well as its role in homeostasis and disease. Furthermore, we summarize the findings on cell subpopulations with regenerative potential that might enable the formation of new β-cells in diseased state. Finally, we review new data on the transcriptional program and function of rare pancreatic cell types and their implication in diabetes.MAJOR CONCLUSION:Novel, single-cell technologies offer high molecular resolution of cellular heterogeneity within the pancreas and provide information on processes and factors that govern β-cell homeostasis, proliferation, and maturation. Eventually, these technologies might lead to the characterization of cells with regenerative potential and unravel disease-associated changes in gene expression to identify cellular and molecular targets for therapy.

A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes

Loss of β-cell identity and dedifferentiation, not an irreversible process?

Research Progress on the Mechanism of Beta-Cell Apoptosis in Type 2 Diabetes Mellitus

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Beta cell dedifferentiation in type 1 diabetes: sacrificing function for survival?

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

β cell aging and age-related diabetes

Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review

Unique features of β‐cell metabolism are lost in type 2 diabetes

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells